查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1708220

CBD 營養保健品市場機會、成長動力、產業趨勢分析及 2025 - 2034 年預測

CBD Nutraceuticals Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034
出版日期: | 出版商: Global Market Insights Inc. | 英文 131 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2024 年全球 CBD 營養保健品市場規模達 107 億美元，預估 2025 年至 2034 年期間複合年成長率將達到 17.5%。這一令人印象深刻的成長主要得益於人們越來越意識到大麻二酚 (CBD) 在管理慢性病和促進整體健康方面的益處。隨著越來越多的消費者將注意力轉向植物性、清潔標籤和健康產品，對 CBD 營養保健品的需求持續成長。消費者正在尋求傳統藥物的天然替代品，導致人們對基於 CBD 的補充劑的興趣激增，這些補充劑具有抗炎、鎮痛和緩解壓力的功效，而且沒有成癮風險。此外，人工智慧 (AI) 驅動的個人化工具的進步透過指導產品選擇和提供客製化建議顯著增強了客戶體驗。

CBD 營養保健品市場 - IMG1

除此之外，該行業正在經歷向永續、有機 CBD 種植實踐的重大轉變，從而產生更高效、更具成本效益的提取方法，使新舊參與者都受益。人們對環保生產方法的傾向日益增強，為品牌創造了機會，使其能夠在保持高品質標準的同時滿足具有環保意識的消費者的需求。此外，有利的監管框架（尤其是在美國等主要市場）正在鼓勵進一步投資並推動 CBD 營養保健品領域的創新。

市場範圍
起始年份 2024
預測年份 2025-2034
起始值 107億美元
預測值 531億美元
複合年成長率 17.5%

市場分為幾個產品類別，包括 CBD 油、酊劑、膠囊、軟膠囊、軟糖和其他形式。 CBD 油已成為最受歡迎的細分市場，2023 年的市值為 30 億美元。這些油以其高吸收率和易於使用而聞名，可有效緩解慢性疼痛、壓力和焦慮。 CBD 油透過舌下給藥，作用迅速、有效，是尋求快速起效和持久效果的個人的首選。這些油具有各種濃度，可滿足廣泛的消費者偏好和治療需求，使其成為市場上用途最廣泛的產品之一。

CBD 營養保健品的應用涵蓋疼痛管理、睡眠障礙、心理健康、減輕壓力和其他健康問題。疼痛管理領域佔據市場主導地位，到 2024 年將佔據 35.5% 的顯著佔有率，這主要是由於關節炎、纖維肌痛和偏頭痛等慢性疼痛疾病的盛行率不斷上升。 CBD 已被證實具有抗發炎和鎮痛特性，使其成為比傳統止痛藥更安全、更有效的替代品，而傳統止痛藥通常會帶來不良的副作用。由於 CBD 不具成癮性且能夠提供持續緩解，醫療保健提供者和患者都擴大選擇它。

預計到 2034 年，美國 CBD 營養保健品市場將創造 257 億美元的產值，在 2025 年至 2034 年期間保持 17.5% 的強勁複合年成長率。作為全球最大的 CBD 營養保健品市場，美國受益於有利的法規、較高的消費者認知度以及大麻衍生產品日益成長的接受度。關節炎、焦慮症和睡眠障礙等慢性病發病率的不斷上升，進一步刺激了該地區對基於 CBD 的營養保健品的需求。不斷變化的監管環境和對 CBD 治療潛力的持續研究預計將推動持續成長，使美國市場處於全球 CBD 營養保健品產業的前沿。

目錄

第1章：方法論與範圍

第2章：執行摘要

第3章：行業洞察

  • 產業生態系統分析
  • 產業衝擊力
    • 成長動力
      • 慢性病和精神健康障礙盛行率上升
      • 對植物性和天然補充劑的需求不斷成長
      • 產品開發和配方的創新
    • 產業陷阱與挑戰
      • CBD提取和產品開發成本高
      • 消費者對 CBD 的教育有限且有誤解
  • 成長潛力分析
  • 監管格局
  • 未來市場趨勢
  • 波特的分析
  • PESTEL分析

第4章：競爭格局

  • 介紹
  • 公司市佔率分析
  • 公司矩陣分析
  • 主要市場參與者的競爭分析
  • 競爭定位矩陣
  • 策略儀表板

第5章：市場估計與預測：依產品類型，2021-2034

  • 主要趨勢
  • CBD油
  • CBD酊劑
  • CBD膠囊和軟膠囊
  • CBD軟糖和咀嚼片
  • 其他產品類型

第6章：市場估計與預測：按應用，2021-2034

  • 主要趨勢
  • 疼痛管理
  • 減輕焦慮和壓力
  • 睡眠障礙
  • 心理健康
  • 其他應用

第7章：市場估計與預測：按配銷通路，2021-2034 年

  • 主要趨勢
  • 零售店
  • 藥局
  • 電子商務
  • 其他分銷管道

第8章：市場估計與預測：按地區，2021-2034

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 荷蘭
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • MEA
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第9章：公司簡介

  • Bluebird Botanicals
  • Charlotte's Web
  • CV Sciences
  • Diamond CBD
  • Elixinol
  • ENDOCA
  • Foria Wellness
  • Garden of Life (Nestle)
  • Green Roads
  • Irwin Naturals
  • Isodiol
  • Medical Marijuana
  • MEDTERRA
簡介目錄
Product Code: 13355

The Global CBD Nutraceuticals Market generated USD 10.7 billion in 2024 and is expected to grow at a remarkable CAGR of 17.5% from 2025 to 2034. This impressive growth is primarily driven by the increasing awareness of the health benefits of cannabidiol (CBD) in managing chronic conditions and promoting overall wellness. As more consumers shift their focus toward plant-based, clean-label, and health-enhancing products, the demand for CBD nutraceuticals continues to gain momentum. Consumers are seeking natural alternatives to traditional medications, leading to a surge in interest in CBD-based supplements that offer anti-inflammatory, analgesic, and stress-relief properties without the risk of addiction. Furthermore, advancements in personalization tools powered by artificial intelligence (AI) have significantly enhanced customer experiences by guiding product choices and offering tailored recommendations.

CBD Nutraceuticals Market - IMG1

Alongside this, the industry is witnessing a major transition toward sustainable, organic CBD farming practices, resulting in more efficient and cost-effective extraction methods that are benefiting both new and established players. The rising inclination toward eco-friendly production methods is creating opportunities for brands to cater to environmentally conscious consumers while maintaining high-quality standards. Additionally, favorable regulatory frameworks, particularly in key markets such as the United States, are encouraging further investments and driving innovation in the CBD nutraceuticals space.

Market Scope
Start Year2024
Forecast Year2025-2034
Start Value$10.7 Billion
Forecast Value$53.1 Billion
CAGR17.5%

The market is segmented into several product categories, including CBD oils, tinctures, capsules, soft gels, gummies, and other forms. CBD oils have emerged as the most popular segment, generating USD 3 billion in 2023. These oils, known for their high absorption rate and ease of use, provide effective relief from chronic pain, stress, and anxiety. Administered sublingually, CBD oils act quickly and efficiently, making them a preferred choice for individuals seeking fast-acting and long-lasting effects. Available in various concentrations, these oils cater to a wide range of consumer preferences and therapeutic needs, making them one of the most versatile products in the market.

The application of CBD nutraceuticals spans across pain management, sleep disorders, mental health, stress reduction, and other health concerns. The pain management segment dominated the market with a significant share of 35.5% in 2024, driven by the increasing prevalence of chronic pain conditions such as arthritis, fibromyalgia, and migraines. CBD's proven anti-inflammatory and analgesic properties have positioned it as a safer and more effective alternative to traditional pain medications, which often come with undesirable side effects. Both healthcare providers and patients are increasingly opting for CBD due to its non-addictive nature and ability to provide sustained relief.

The U.S. CBD nutraceuticals market is projected to generate USD 25.7 billion by 2034, maintaining a robust CAGR of 17.5% from 2025 to 2034. As the largest market for CBD nutraceuticals globally, the U.S. benefits from favorable regulations, high consumer awareness, and increasing acceptance of cannabis-derived products. The growing incidence of chronic conditions, including arthritis, anxiety, and sleep disorders, has further fueled the demand for CBD-based nutraceuticals in the region. The evolving regulatory landscape and ongoing research into the therapeutic potential of CBD are expected to drive sustained growth, positioning the U.S. market at the forefront of the global CBD nutraceuticals industry.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates and calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 3600 synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Rising prevalence of chronic diseases and mental health disorders
      • 3.2.1.2 Growing demand for plant-based and natural supplements
      • 3.2.1.3 Innovations in product development and formulations
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 High costs of CBD extraction and product development
      • 3.2.2.2 Limited consumer education and misconceptions about CBD
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Future market trends
  • 3.6 Porter's analysis
  • 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Company matrix analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product Type, 2021-2034 ($ Mn)

  • 5.1 Key trends
  • 5.2 CBD oils
  • 5.3 CBD tinctures
  • 5.4 CBD capsules and softgels
  • 5.5 CBD gummies and chews
  • 5.6 Other product types

Chapter 6 Market Estimates and Forecast, By Application, 2021-2034 ($ Mn)

  • 6.1 Key trends
  • 6.2 Pain management
  • 6.3 Anxiety and stress reduction
  • 6.4 Sleep disorders
  • 6.5 Mental health
  • 6.6 Other applications

Chapter 7 Market Estimates and Forecast, By Distribution Channel, 2021-2034 ($ Mn)

  • 7.1 Key trends
  • 7.2 Retail stores
  • 7.3 Pharmacies
  • 7.4 E-commerce
  • 7.5 Other distribution channels

Chapter 8 Market Estimates and Forecast, By Region, 2021-2034 ($ Mn)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Spain
    • 8.3.5 Italy
    • 8.3.6 Netherlands
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 South Korea
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
  • 8.6 MEA
    • 8.6.1 South Africa
    • 8.6.2 Saudi Arabia
    • 8.6.3 UAE

Chapter 9 Company Profiles

  • 9.1 Bluebird Botanicals
  • 9.2 Charlotte's Web
  • 9.3 CV Sciences
  • 9.4 Diamond CBD
  • 9.5 Elixinol
  • 9.6 ENDOCA
  • 9.7 Foria Wellness
  • 9.8 Garden of Life (Nestle)
  • 9.9 Green Roads
  • 9.10 Irwin Naturals
  • 9.11 Isodiol
  • 9.12 Medical Marijuana
  • 9.13 MEDTERRA